查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2004550

髂動脈支架市場報告：趨勢、預測及競爭分析（至2035年）

Iliac Stent Market Report: Trends, Forecast and Competitive Analysis to 2035
出版日期: | 出版商: Lucintel | 英文 150 Pages | 商品交期: 3個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

全球髂動脈支架市場前景廣闊，預計在醫院和門診領域都有發展機會。 2026年至2035年，全球髂動脈支架市場預計將以5.5%的複合年成長率成長，到2035年市場規模預計將達到23億美元。推動市場成長的主要因素包括周邊動脈疾病盛行率的上升、對微創治療需求的成長以及先進支架技術的廣泛應用。

  • 根據 Lucintel 的預測，根據所使用的支架類型，自動擴張型支架在預測期內預計將呈現更高的成長率。
  • 從應用場景來看，門診設施預計將呈現更高的成長率。
  • 按地區分類，預計亞太地區在預測期內將呈現最高的成長率。

髂動脈支架市場的新趨勢

髂動脈支架市場正經歷快速發展，其驅動力包括技術進步、周邊動脈疾病盛行率上升以及微創手術日益普及。隨著醫療專業人員對更有效、更持久的解決方案的需求不斷成長，市場參與者也持續創新以滿足這一需求。新材料的引入、支架設計的改進以及個人化治療方案的出現正在塑造未來的市場模式。此外，監管政策的變化和醫療成本的上漲也在影響市場動態。這些趨勢共同造就了一個更具競爭性、創新性和以患者為中心的市場環境，最終將帶來更好的臨床療效，並擴大患者獲得先進血管介入治療的機會。

  • 技術創新：支架設計和材料領域正取得顯著進展，包括生物可吸收支架和藥物釋放型支架。這些創新旨在提高血管通暢率、降低血管再阻塞並增強生物相容性。此外，影像技術和輸送系統的改進提高了手術精度並降低了創傷性。這一趨勢正在推動新一代髂動脈支架的研發，這些支架具有更高的耐用性、柔軟性和更好的患者預後，從而擴大了微創血管介入治療的範圍。
  • 周邊動脈疾病(PAD) 發病率上升：全球 PAD 病例數量不斷增加，這主要歸因於人口老化、糖尿病和生活方式因素，從而推動了對髂動脈支架的需求。隨著越來越多的患者需要接受血管重建手術，市場正在擴大。這一趨勢凸顯了對能夠解決複雜病變並改善患者生活品質的耐用有效支架解決方案的需求。不斷成長的患者群體也促使醫療專業人員採用先進的支架留置技術，進一步推動了市場成長。
  • 微創手術的興起：從傳統開放性手術轉向微創血管內置入術技術是一個顯著的趨勢。髂動脈支架置放術可縮短恢復時間、降低併發症率並最大限度地減少手術相關不適。影像和輸送系統的技術進步推動了這一趨勢，提高了手術的安全性和可及性。隨著患者偏好和臨床指南推薦微創方案，髂動脈支架置入術市場預計將穩定成長，其應用範圍也將擴展到所有醫療機構。
  • 監管和報銷體系的變化：監管標準和報銷政策的演變正在影響市場動態。新支架器械核准流程的收緊促進了創新，但也可能為市場准入帶來挑戰。另一方面，優惠的報銷政策獎勵醫療機構採用先進的支架治療方案。這些監管和財務因素正在影響產品開發、定價策略和市場准入，重塑競爭格局，並促使企業更加重視合規性和以價值為導向的醫療保健。
  • 市場擴張與地理成長：亞太、拉丁美洲和中東等新興市場的醫療基礎設施不斷完善，人們對血管疾病的認知度也日益提高。這種擴張為髂動脈支架製造商帶來了巨大的成長機會。在地化生產、策略合作以及針對區域市場量身定做的產品方案正在推動這些地區的市場滲透。隨著醫療服務可及性的提升和經濟狀況的趨於穩定，預計這些市場將為全球市場成長做出重大貢獻，豐富競爭組織，並促進創新。

總而言之，這些趨勢正透過促進創新、擴大應用範圍和改善患者預後，全面改變髂動脈支架市場。技術進步、人口結構變化、治療方法偏好、監管環境以及對地理擴張的關注，共同創造了一個充滿活力的環境，為持續成長和發展奠定了基礎。

髂動脈支架市場的最新趨勢

髂動脈支架市場正經歷快速成長，這主要得益於技術進步、血管疾病盛行率上升以及全球醫療基礎設施的不斷改進。支架設計和材料的創新正在改善患者的治療效果，而公眾意識的提高和篩檢項目的廣泛應用也推動了市場需求。此外，策略合作和監管核准也促進了市場擴張。市場的發展趨勢反映了對微創手術和個人化醫療的關注，為永續成長奠定了基礎。這些趨勢正在重塑市場格局，為相關人員帶來新的機遇，並有助於提升全球患者照護水準。

  • 支架技術創新：先進的髂動脈支架的研發，憑藉其更高的柔軟性、耐用性和生物相容性，正在改變治療選擇。新材料和設計改進降低了血管再阻塞和併發症率，從而改善了長期療效。這項創新吸引了尋求有效且微創解決方案的醫療專業人員，進而推動了市場擴張。隨著研究的深入，藥物釋放型支架和生物可吸收支架的整合可望進一步改變市場模式，提供滿足不同患者需求的個人治療方法。
  • 血管疾病盛行率上升：全球周邊動脈疾病和動脈粥狀硬化的發生率不斷上升，顯著推動了髂動脈支架的需求。老化和生活方式因素加劇了血管健康問題，需要更多治療性介入。早期診斷和篩檢項目的改進，使得更多適合支架置入術的患者得以識別，擴大了患者群體。這一趨勢凸顯了對更便利、更有效治療方法的需求，推動了市場成長，並激勵製造商進行創新和提高產量。
  • 醫療基礎設施的擴張：醫療設施的增加，尤其是在新興國家，正在促進血管疾病治療的普及。對配備先進診斷和手術設備的醫院和診所的投資，推動了手術數量的成長。政府措施和官民合作關係進一步促進了基礎設施建設。這種擴建將增加髂動脈支架手術的可近性，降低治療成本，加快市場滲透，最終改善患者預後，並推動產業成長。
  • 策略合作與監管核准：醫療設備製造商與醫療服務提供者之間的合作正在加速產品開發和商業化。在美國和歐洲等關鍵市場獲得監管核准，正推動創新支架的廣泛應用。這些策略性措施有助於產品進入市場，確保合規性，並增強消費者信心。隨著核准和合作的增加，市場將受益於更廣泛的先進醫療設備，競爭也將加劇，並促進創新以滿足多樣化的臨床需求。
  • 微創手術需求日益成長：微創治療方法的轉變是髂動脈支架市場的主要驅動力。由於患者傾向於恢復時間更短、併發症更少的手術，臨床醫生擴大採用血管內介入技術。這種需求促使製造商開發出操作簡單、性能卓越且與微創手術相容的支架。這一趨勢提高了手術成功率和患者滿意度，從而擴大了支架的應用範圍並促進了市場成長，尤其是在門診和近門診環境中。

這些趨勢共同推動了髂動脈支架市場的顯著成長。技術創新、疾病盛行率上升、基礎設施擴建、策略合作以及患者對微創手術的偏好，共同創造了一個充滿活力的市場環境。這種發展不僅擴大了市場規模，也有助於改善治療效果和提高醫療服務的可近性。隨著這些因素的持續演變，預計市場將保持持續成長，為相關人員帶來廣泛的機遇，並為全球患者提供更優質的醫療解決方案。

目錄

第1章執行摘要

第2章 市場概覽

  • 背景與分類
  • 供應鏈

第3章 市場趨勢與預測分析

  • 宏觀經濟趨勢與預測
  • 產業促進因素與挑戰
  • PESTLE分析
  • 專利分析
  • 法規環境

第4章：全球髂動脈支架市場：依類型分類

  • 吸引力分析：按類型
  • 自動擴張型支架
  • 球囊擴張型支架
  • 其他

第5章：全球髂動脈支架市場：依動脈病變類型分類

  • 吸引力分析：依動脈疾病類型分類
  • 髂總動脈病變
  • 嚴重鈣化病灶
  • 完全閉塞性病變

第6章：全球髂動脈支架市場：依最終用途分類

  • 吸引力分析：依最終用途分類
  • 醫院
  • 門診設施
  • 其他

第7章 區域分析

第8章：北美髂動脈支架市場

  • 北美髂動脈支架市場：依類型分類
  • 北美髂動脈支架市場：依最終用途分類
  • 美國髂骨支架市場
  • 加拿大髂動脈支架市場
  • 墨西哥髂動脈支架市場

第9章：歐洲髂動脈支架市場

  • 歐洲髂動脈支架市場：依類型分類
  • 歐洲髂動脈支架市場：依最終用途分類
  • 德國髂動脈支架市場
  • 法國髂骨支架市場
  • 義大利髂動脈支架市場
  • 西班牙髂動脈支架市場
  • 英國髂動脈支架市場

第10章：亞太地區髂動脈支架市場

  • 亞太地區髂動脈支架市場：依類型分類
  • 亞太地區髂動脈支架市場：依最終用途分類
  • 中國髂動脈支架市場
  • 印度髂動脈支架市場
  • 日本髂動脈支架市場
  • 韓國髂動脈支架市場
  • 印尼髂動脈支架市場

第11章：世界其他地區的髂動脈支架市場

  • 其他地區的髂動脈支架市場：按類型分類
  • 其他地區髂動脈支架市場：依最終用途分類
  • 中東髂骨支架市場
  • 南非髂動脈支架市場
  • 非洲髂動脈支架市場

第12章 競爭分析

  • 產品系列分析
  • 業務整合
  • 波特五力分析
  • 市佔率分析

第13章 機會與策略分析

  • 價值鏈分析
  • 成長機會分析
  • 新趨勢：全球髂動脈支架市場
  • 戰略分析

第14章：價值鏈中主要企業的公司概況

  • 競爭分析概述
  • BD
  • Abbott
  • Boston Scientific Corporation
  • WL Gore & Associates, Inc.
  • Medtronic
  • Cook
  • Terumo Corporation
  • iVascular
  • Getinge AB
  • Biotronik SE & Co KG

第15章附錄

The future of the global iliac stent market looks promising with opportunities in the hospital and outpatient facility markets. The global iliac stent market is expected to reach an estimated $2.3 billion by 2035 with a CAGR of 5.5% from 2026 to 2035. The major drivers for this market are the increasing prevalence of peripheral artery diseases, the rising demand for minimally invasive treatments, and the growing adoption of advanced stent technologies.

  • Lucintel forecasts that, within the type category, self-expandable stent is expected to witness higher growth over the forecast period.
  • Within the end use category, outpatient facility is expected to witness higher growth.
  • In terms of region, APAC is expected to witness the highest growth over the forecast period.

Emerging Trends in the Iliac Stent Market

The iliac stent market is experiencing rapid evolution driven by technological advancements, increasing prevalence of peripheral artery disease, and a growing emphasis on minimally invasive procedures. As healthcare providers seek more effective and durable solutions, market players are innovating to meet these demands. The integration of new materials, improved stent designs, and personalized treatment options is shaping the future landscape. Additionally, regulatory changes and rising healthcare expenditure are influencing market dynamics. These developments collectively contribute to a more competitive, innovative, and patient-centric market environment, ultimately improving clinical outcomes and expanding access to advanced vascular interventions.

  • Technological Innovation: The market is witnessing significant advancements in stent design and materials, such as bioresorbable and drug-eluting stents. These innovations aim to improve patency rates, reduce restenosis, and enhance biocompatibility. Enhanced imaging and delivery systems are also making procedures more precise and less invasive. This trend is driving the development of next-generation iliac stents that offer better durability, flexibility, and patient outcomes, thereby expanding the scope of minimally invasive vascular interventions.
  • Rising Prevalence of Peripheral Artery Disease: An increase in PAD cases globally, driven by aging populations, diabetes, and lifestyle factors, is fueling demand for iliac stents. As more patients require revascularization procedures, the market expands. This trend underscores the need for durable, effective stent solutions that can address complex lesions and improve quality of life. The growing patient pool is also encouraging healthcare providers to adopt advanced stenting techniques, further propelling market growth.
  • Adoption of Minimally Invasive Procedures: The shift from traditional open surgeries to minimally invasive endovascular techniques is a key trend. Iliac stenting offers reduced recovery times, lower complication rates, and less procedural discomfort. This trend is supported by technological improvements in imaging and delivery systems, making procedures safer and more accessible. As patient preference and clinical guidelines favor minimally invasive options, the market for iliac stents is expected to grow steadily, with increased adoption across healthcare settings.
  • Regulatory and Reimbursement Changes: Evolving regulatory standards and reimbursement policies are impacting market dynamics. Stricter approval processes for new stent devices are encouraging innovation but may also pose challenges for market entry. Conversely, favorable reimbursement policies are incentivizing healthcare providers to adopt advanced stenting solutions. These regulatory and financial factors influence product development, pricing strategies, and market accessibility, shaping the competitive landscape and encouraging companies to focus on compliance and value-based care.
  • Market Expansion and Geographic Growth: Emerging markets in Asia-Pacific, Latin America, and the Middle East are experiencing increased healthcare infrastructure development and rising awareness about vascular diseases. This expansion offers significant growth opportunities for iliac stent manufacturers. Local manufacturing, strategic partnerships, and tailored product offerings are facilitating market penetration in these regions. As healthcare access improves and economic conditions stabilize, these markets are expected to contribute substantially to global market growth, diversifying the competitive landscape and fostering innovation.

In summary, these trends are collectively transforming the iliac stent market by fostering innovation, expanding access, and improving patient outcomes. The focus on technological advancements, demographic shifts, procedural preferences, regulatory landscapes, and geographic expansion is creating a dynamic environment that is poised for sustained growth and evolution.

Recent Developments in the Iliac Stent Market

The iliac stent market is experiencing rapid growth driven by technological advancements, increasing vascular disease prevalence, and expanding healthcare infrastructure worldwide. Innovations in stent design and materials are improving patient outcomes, while rising awareness and screening programs are boosting demand. Additionally, strategic collaborations and regulatory approvals are facilitating market expansion. The markets evolution reflects a focus on minimally invasive procedures and personalized treatments, positioning it for sustained growth. These developments are reshaping the landscape, offering new opportunities for stakeholders and improving patient care globally.

  • Innovation in Stent Technology: The development of advanced iliac stents with improved flexibility, durability, and biocompatibility is transforming treatment options. New materials and design enhancements reduce restenosis and complications, leading to better long-term outcomes. This innovation attracts healthcare providers seeking effective, minimally invasive solutions, thereby expanding market reach. As research continues, the integration of drug-eluting and bioresorbable stents is expected to further revolutionize the market, offering tailored therapies for diverse patient needs.
  • Increasing Prevalence of Vascular Diseases: The rising incidence of peripheral artery disease and atherosclerosis globally is significantly driving iliac stent demand. Aging populations and lifestyle factors contribute to vascular health issues, prompting more interventions. Early diagnosis and improved screening programs are identifying candidates for stenting procedures, expanding the patient base. This trend underscores the need for accessible, effective treatment options, fueling market growth and encouraging manufacturers to innovate and scale production.
  • Expanding Healthcare Infrastructure: Growth in healthcare facilities, especially in emerging economies, is facilitating wider access to vascular interventions. Investments in hospitals and clinics equipped with advanced diagnostic and surgical tools are increasing procedural volumes. Government initiatives and public-private partnerships are further supporting infrastructure development. This expansion enhances the availability of iliac stent procedures, reduces treatment costs, and accelerates market penetration, ultimately improving patient outcomes and fostering industry growth.
  • Strategic Partnerships and Regulatory Approvals: Collaborations between medical device companies and healthcare providers are accelerating product development and commercialization. Regulatory approvals in key markets, such as the U.S. and Europe, are enabling wider adoption of innovative stents. These strategic moves streamline market entry, ensure compliance, and boost consumer confidence. As approvals and partnerships multiply, the market benefits from a broader portfolio of advanced devices, increasing competition, and driving innovation to meet diverse clinical needs.
  • Rising Demand for Minimally Invasive Procedures: The shift towards less invasive treatments is a key driver in the iliac stent market. Patients prefer procedures with shorter recovery times and fewer complications, prompting clinicians to adopt endovascular techniques. This demand encourages manufacturers to develop user-friendly, high-performance stents compatible with minimally invasive approaches. The trend enhances procedural success rates and patient satisfaction, leading to increased adoption and market expansion, especially in outpatient and outpatient-like settings.

These developments collectively are propelling the iliac stent market towards significant growth. Technological innovations, rising disease prevalence, infrastructure expansion, strategic collaborations, and patient preferences for minimally invasive procedures are creating a dynamic environment. This evolution is not only expanding market size but also improving treatment outcomes and accessibility. As these factors continue to evolve, the market is poised for sustained growth, offering promising opportunities for industry stakeholders and better healthcare solutions for patients worldwide.

Strategic Growth Opportunities in the Iliac Stent Market

The iliac stent market is experiencing significant growth driven by increasing peripheral artery disease cases, technological advancements, and expanding healthcare infrastructure. Rising awareness and demand for minimally invasive procedures further propel market expansion. Key applications across various medical settings are creating new opportunities for manufacturers and healthcare providers. Strategic investments and innovation are essential to capitalize on these trends, ensuring improved patient outcomes and market competitiveness. This dynamic environment offers substantial potential for growth, making it a critical focus for stakeholders aiming to enhance vascular intervention solutions.

  • Increasing Prevalence of Peripheral Artery Disease: The rising incidence of peripheral artery disease (PAD) globally is a primary driver for iliac stent adoption. As PAD progresses, patients require minimally invasive interventions like iliac stenting to restore blood flow. The aging population and lifestyle-related risk factors contribute to this trend, expanding the patient pool. Healthcare providers are increasingly opting for iliac stents over traditional surgery due to reduced recovery times and improved outcomes, fueling market growth.
  • Advancements in Stent Technology and Materials: Innovations in stent design, such as drug-eluting and bioresorbable stents, are enhancing treatment efficacy and patient safety. New materials improve flexibility, durability, and biocompatibility, reducing complications like restenosis. These technological advancements enable more precise placement and longer-lasting results, encouraging wider adoption. Continuous R&D efforts are expected to introduce next-generation stents, further expanding the market and offering tailored solutions for diverse patient needs.
  • Rising Demand for Minimally Invasive Procedures: The shift towards minimally invasive vascular interventions is a significant growth factor. Iliac stenting offers a less traumatic alternative to open surgery, with shorter hospital stays and quicker recovery. Patients and clinicians prefer these procedures for their safety and convenience. As healthcare systems prioritize outpatient treatments, the demand for iliac stents increases, prompting manufacturers to develop user-friendly, cost-effective devices that support minimally invasive techniques.
  • Expanding Healthcare Infrastructure and Access: Growing healthcare infrastructure, especially in emerging economies, improves access to vascular treatments. Investments in hospitals and specialized clinics facilitate the adoption of iliac stenting procedures. Government initiatives and public-private partnerships aim to enhance diagnostic and treatment facilities, broadening patient reach. This expansion supports market growth by enabling more widespread use of iliac stents, particularly in regions with previously limited access to advanced vascular care.
  • Strategic Partnerships and Market Consolidation: Collaborations between device manufacturers, healthcare providers, and research institutions foster innovation and market expansion. Mergers and acquisitions consolidate market share, streamline product portfolios, and accelerate development of advanced stents. Strategic partnerships also facilitate clinical trials and regulatory approvals, boosting product credibility. These activities help companies penetrate new markets and meet evolving clinical demands, ensuring sustained growth and competitiveness in the iliac stent market.

The overall impact of these opportunities is a robust expansion of the iliac stent market, driven by technological innovation, increased disease prevalence, and improved healthcare access. Stakeholders who leverage these growth avenues can enhance treatment outcomes, expand their market presence, and meet the rising demand for minimally invasive vascular solutions. This evolving landscape promises sustained growth and innovation, shaping the future of vascular intervention therapies.

Iliac Stent Market Driver and Challenges

The iliac stent market is influenced by a variety of technological, economic, and regulatory factors that shape its growth trajectory. Advances in minimally invasive procedures and stent technology have increased the adoption of iliac stents worldwide. Economic factors such as rising healthcare expenditure and increasing prevalence of peripheral artery disease (PAD) further propel market expansion. Regulatory approvals and guidelines ensure safety and efficacy, fostering confidence among healthcare providers and patients. However, challenges like high costs, stringent regulatory processes, and technological limitations pose hurdles. Understanding these drivers and challenges is essential for stakeholders to navigate the evolving landscape and capitalize on emerging opportunities.

The factors responsible for driving the iliac stent market include:

  • Technological Innovations: The development of advanced stent materials and designs, such as drug-eluting and bioresorbable stents, has significantly improved patient outcomes. These innovations reduce restenosis rates and enhance durability, making procedures more effective and appealing to clinicians. Continuous R&D efforts are leading to more precise, minimally invasive interventions, which expand the patient pool eligible for treatment. As technology advances, costs tend to decrease, further promoting adoption across various healthcare settings. The integration of imaging and navigation systems also enhances procedural accuracy, boosting confidence among practitioners and patients alike.
  • Increasing Prevalence of Peripheral Artery Disease (PAD): The rising incidence of PAD, especially among aging populations and those with diabetes or hypertension, is a major growth driver. As PAD progresses, patients often require revascularization procedures, including iliac stent placement. The growing burden of cardiovascular diseases globally, coupled with lifestyle changes and urbanization, has led to increased diagnosis and treatment rates. This trend directly correlates with higher demand for minimally invasive solutions like iliac stents, fueling market expansion. Governments and healthcare providers are prioritizing early diagnosis and intervention, further supporting market growth.
  • Favorable Reimbursement Policies: Improved reimbursement frameworks in many regions have made iliac stent procedures more accessible and affordable. Insurance coverage and government schemes reduce out-of-pocket expenses for patients, encouraging more individuals to seek treatment. Reimbursement policies that recognize the long-term cost savings of minimally invasive procedures over traditional surgery also incentivize healthcare providers to adopt iliac stents. This financial support accelerates market penetration, especially in emerging economies where cost barriers previously limited access. As reimbursement policies continue to evolve favorably, market growth is expected to accelerate further.
  • Growing Healthcare Infrastructure: The expansion of healthcare infrastructure, particularly in developing countries, facilitates increased access to advanced vascular interventions. Investments in hospitals, clinics, and specialized vascular centers enable more patients to receive timely diagnosis and treatment. The availability of trained healthcare professionals and modern equipment supports the adoption of iliac stents. Additionally, collaborations between public and private sectors are improving healthcare delivery, making minimally invasive procedures more widespread. This infrastructure development not only boosts current market demand but also lays the foundation for sustained growth as awareness and accessibility increase.
  • Rising Awareness and Screening Programs: Increased awareness about PAD and peripheral vascular diseases, along with widespread screening initiatives, has led to earlier diagnosis and intervention. Educational campaigns targeting high-risk populations promote understanding of treatment options, including iliac stents. Early detection allows for less invasive procedures, reducing complications and improving quality of life. The proliferation of screening programs in both developed and developing countries ensures a steady pipeline of patients eligible for stent placement. This heightened awareness directly correlates with increased procedure volumes, supporting overall market growth.

The challenges facing this iliac stent market include:

  • High Cost of Devices and Procedures: The advanced technology involved in manufacturing iliac stents, especially drug-eluting and bioresorbable types, results in high device costs. Additionally, procedural expenses, including hospital stays and specialist fees, can be prohibitive for some patients and healthcare systems. This financial barrier limits access, particularly in low- and middle-income countries, restricting market growth. Reimbursement limitations and budget constraints further exacerbate the issue, making it difficult for providers to adopt the latest technologies widely. Overcoming cost-related challenges is crucial for expanding market reach and ensuring equitable access to treatment.
  • Stringent Regulatory Environment: The approval process for new iliac stent devices involves rigorous testing and compliance with safety and efficacy standards set by regulatory authorities. Lengthy approval timelines and complex documentation requirements can delay product launches and market entry. Variability in regulations across regions adds complexity for manufacturers aiming for global distribution. These regulatory hurdles increase costs and time-to-market, potentially discouraging innovation and limiting product availability. Navigating this landscape requires significant resources and strategic planning, which can be challenging for smaller companies and startups.
  • Technological Limitations and Complications: Despite advancements, certain limitations persist, such as stent thrombosis, restenosis, and device migration. These complications can lead to repeat procedures and adverse patient outcomes, impacting market confidence. Additionally, some patients may not be suitable candidates for stent placement due to anatomical or comorbid conditions. Technological limitations also include issues related to long-term durability and biocompatibility. Addressing these challenges requires ongoing research and development, which can be resource-intensive. Overcoming these limitations is essential for improving patient outcomes and expanding the market.

In summary, the iliac stent market is driven by technological innovations, increasing disease prevalence, supportive reimbursement policies, expanding healthcare infrastructure, and heightened awareness. However, high costs, regulatory complexities, and technological limitations pose significant challenges. These factors collectively influence market dynamics, with growth prospects hinging on the ability to address barriers and leverage opportunities. As technological and regulatory landscapes evolve, stakeholders must focus on cost reduction, innovation, and improved patient outcomes to sustain growth and competitiveness in this expanding market.

List of Iliac Stent Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies iliac stent companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the iliac stent companies profiled in this report include-

  • BD
  • Abbott
  • Boston Scientific Corporation
  • W. L. Gore & Associates, Inc.
  • Medtronic
  • Cook
  • Terumo Corporation
  • iVascular
  • Getinge AB
  • Biotronik SE & Co KG

Iliac Stent Market by Segment

The study includes a forecast for the global iliac stent market by type, artery lesions, end use, and region.

Iliac Stent Market by Type [Value from 2019 to 2035]:

  • Self-expandable Stents
  • Balloon-expandable Stents
  • Others

Iliac Stent Market by Artery Lesions [Value from 2019 to 2035]:

  • Common Iliac Artery Lesions
  • Severe Calcified Lesions
  • Complete Obstructive Lesions

Iliac Stent Market by End Use [Value from 2019 to 2035]:

  • Hospitals
  • Outpatient Facilities
  • Others

Iliac Stent Market by Region [Value from 2019 to 2035]:

  • North America
  • Europe
  • Asia Pacific
  • The Rest of the World

Country Wise Outlook for the Iliac Stent Market

The iliac stent market has experienced significant growth driven by technological advancements, increasing prevalence of peripheral artery disease, and expanding healthcare infrastructure worldwide. Countries are adopting innovative stent designs and materials to improve patient outcomes, reduce complications, and enhance procedural success rates. Regulatory approvals and rising awareness about minimally invasive treatments are further propelling market expansion. Each country's unique healthcare policies, technological adoption, and patient demographics influence the pace and nature of developments in this sector. Understanding these regional trends is crucial for stakeholders aiming to capitalize on emerging opportunities and address unmet clinical needs effectively.

  • United States: The US market has seen rapid adoption of drug-eluting iliac stents, driven by high healthcare expenditure and advanced medical infrastructure. Innovations such as bioresorbable stents and improved imaging techniques are gaining popularity. Regulatory agencies like the FDA are approving new devices that offer better flexibility and durability, enhancing patient outcomes. The increasing prevalence of peripheral artery disease among aging populations and rising awareness about minimally invasive procedures are key factors fueling growth. Additionally, collaborations between medical device companies and healthcare providers are fostering innovation and expanding access to advanced iliac stent options.
  • China: China's iliac stent market is expanding due to rising cases of peripheral artery disease linked to increasing urbanization, sedentary lifestyles, and a growing aging population. The government's focus on healthcare reforms and expanding insurance coverage has improved access to vascular interventions. Local manufacturers are investing in R&D to develop cost-effective, high-quality stents tailored to regional needs. Technological adoption is accelerating, with a focus on minimally invasive procedures and improved device performance. The market is also benefiting from international collaborations and regulatory support, which facilitate the entry of advanced stent technologies into the Chinese healthcare system.
  • Germany: Germany's market is characterized by high adoption of innovative stent technologies, supported by a well-established healthcare system and stringent regulatory standards. The focus is on developing durable, biocompatible, and customizable iliac stents to improve long-term patency rates. Germany's emphasis on research and development, along with collaborations between academic institutions and industry, drives technological advancements. The aging population and increasing prevalence of peripheral artery disease contribute to steady market growth. Moreover, Germany's strong emphasis on minimally invasive vascular procedures and patient safety standards ensures continuous demand for advanced iliac stent solutions.
  • India: The Indian iliac stent market is witnessing rapid growth due to increasing cases of peripheral artery disease, driven by lifestyle changes and a rising diabetic population. The government's initiatives to improve healthcare infrastructure and affordability are facilitating wider access to vascular interventions. Local manufacturers are focusing on producing cost-effective stents that meet international quality standards, making advanced treatments more accessible. The adoption of minimally invasive techniques is increasing, supported by a growing number of trained specialists. Additionally, rising awareness and expanding healthcare coverage are expected to further propel market growth, with international companies entering the market through partnerships and regulatory approvals.
  • Japan: Japan's iliac stent market is characterized by high technological sophistication and a focus on innovation. The country's aging population significantly contributes to the rising demand for vascular interventions. Japan's regulatory environment encourages the development and approval of advanced stent technologies, including drug-eluting and bioresorbable options. The market benefits from strong healthcare infrastructure, extensive clinical research, and a high prevalence of peripheral artery disease. Japanese manufacturers are investing in R&D to develop next-generation stents with improved biocompatibility and long-term durability. The integration of digital health tools and minimally invasive procedures continues to shape the evolving landscape of the iliac stent market in Japan.

Features of the Global Iliac Stent Market

  • Market Size Estimates: Iliac stent market size estimation in terms of value ($B).
  • Trend and Forecast Analysis: Market trends (2019 to 2025) and forecast (2026 to 2035) by various segments and regions.
  • Segmentation Analysis: Iliac stent market size by type, artery lesions, end use, and region in terms of value ($B).
  • Regional Analysis: Iliac stent market breakdown by North America, Europe, Asia Pacific, and Rest of the World.
  • Growth Opportunities: Analysis of growth opportunities in different types, artery lesions, end uses, and regions for the iliac stent market.
  • Strategic Analysis: This includes M&A, new product development, and competitive landscape of the iliac stent market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

This report answers following 11 key questions:

  • Q.1. What are some of the most promising, high-growth opportunities for the iliac stent market by type (self-expandable stents, balloon-expandable stents, and others), artery lesions (common iliac artery lesions, severe calcified lesions, and complete obstructive lesions), end use (hospitals, outpatient facilities, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
  • Q.2. Which segments will grow at a faster pace and why?
  • Q.3. Which region will grow at a faster pace and why?
  • Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
  • Q.5. What are the business risks and competitive threats in this market?
  • Q.6. What are the emerging trends in this market and the reasons behind them?
  • Q.7. What are some of the changing demands of customers in the market?
  • Q.8. What are the new developments in the market? Which companies are leading these developments?
  • Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
  • Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
  • Q.11. What M&A activity has occurred in the last 7 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Market Overview

  • 2.1 Background and Classifications
  • 2.2 Supply Chain

3. Market Trends & Forecast Analysis

  • 3.1 Macroeconomic Trends and Forecasts
  • 3.2 Industry Drivers and Challenges
  • 3.3 PESTLE Analysis
  • 3.4 Patent Analysis
  • 3.5 Regulatory Environment

4. Global Iliac Stent Market by Type

  • 4.1 Overview
  • 4.2 Attractiveness Analysis by Type
  • 4.3 Self-expandable Stents : Trends and Forecast (2019-2035)
  • 4.4 Balloon-expandable Stents : Trends and Forecast (2019-2035)
  • 4.5 Others : Trends and Forecast (2019-2035)

5. Global Iliac Stent Market by Artery Lesions

  • 5.1 Overview
  • 5.2 Attractiveness Analysis by Artery Lesions
  • 5.3 Common Iliac Artery Lesions : Trends and Forecast (2019-2035)
  • 5.4 Severe Calcified Lesions : Trends and Forecast (2019-2035)
  • 5.5 Complete Obstructive Lesions : Trends and Forecast (2019-2035)

6. Global Iliac Stent Market by End Use

  • 6.1 Overview
  • 6.2 Attractiveness Analysis by End Use
  • 6.3 Hospitals : Trends and Forecast (2019-2035)
  • 6.4 Outpatient Facilities : Trends and Forecast (2019-2035)
  • 6.5 Others : Trends and Forecast (2019-2035)

7. Regional Analysis

  • 7.1 Overview
  • 7.2 Global Iliac Stent Market by Region

8. North American Iliac Stent Market

  • 8.1 Overview
  • 8.2 North American Iliac Stent Market by Type
  • 8.3 North American Iliac Stent Market by End Use
  • 8.4 The United States Iliac Stent Market
  • 8.5 Canadian Iliac Stent Market
  • 8.6 Mexican Iliac Stent Market

9. European Iliac Stent Market

  • 9.1 Overview
  • 9.2 European Iliac Stent Market by Type
  • 9.3 European Iliac Stent Market by End Use
  • 9.4 German Iliac Stent Market
  • 9.5 French Iliac Stent Market
  • 9.6 Italian Iliac Stent Market
  • 9.7 Spanish Iliac Stent Market
  • 9.8 The United Kingdom Iliac Stent Market

10. APAC Iliac Stent Market

  • 10.1 Overview
  • 10.2 APAC Iliac Stent Market by Type
  • 10.3 APAC Iliac Stent Market by End Use
  • 10.4 Chinese Iliac Stent Market
  • 10.5 Indian Iliac Stent Market
  • 10.6 Japanese Iliac Stent Market
  • 10.7 South Korean Iliac Stent Market
  • 10.8 Indonesian Iliac Stent Market

11. ROW Iliac Stent Market

  • 11.1 Overview
  • 11.2 ROW Iliac Stent Market by Type
  • 11.3 ROW Iliac Stent Market by End Use
  • 11.4 Middle Eastern Iliac Stent Market
  • 11.5 South American Iliac Stent Market
  • 11.6 African Iliac Stent Market

12. Competitor Analysis

  • 12.1 Product Portfolio Analysis
  • 12.2 Operational Integration
  • 12.3 Porter's Five Forces Analysis
    • Competitive Rivalry
    • Bargaining Power of Buyers
    • Bargaining Power of Suppliers
    • Threat of Substitutes
    • Threat of New Entrants
  • 12.4 Market Share Analysis

13. Opportunities & Strategic Analysis

  • 13.1 Value Chain Analysis
  • 13.2 Growth Opportunity Analysis
    • 13.2.1 Growth Opportunity by Type
    • 13.2.2 Growth Opportunity by Artery Lesions
    • 13.2.3 Growth Opportunity by End Use
  • 13.3 Emerging Trends in the Global Iliac Stent Market
  • 13.4 Strategic Analysis
    • 13.4.1 New Product Development
    • 13.4.2 Certification and Licensing
    • 13.4.3 Mergers, Acquisitions, Agreements, Collaborations, and Joint Ventures

14. Company Profiles of the Leading Players Across the Value Chain

  • 14.1 Competitive Analysis Overview
  • 14.2 BD
    • Company Overview
    • Iliac Stent Market Business Overview
    • New Product Development
    • Merger, Acquisition, and Collaboration
    • Certification and Licensing
  • 14.3 Abbott
    • Company Overview
    • Iliac Stent Market Business Overview
    • New Product Development
    • Merger, Acquisition, and Collaboration
    • Certification and Licensing
  • 14.4 Boston Scientific Corporation
    • Company Overview
    • Iliac Stent Market Business Overview
    • New Product Development
    • Merger, Acquisition, and Collaboration
    • Certification and Licensing
  • 14.5 W. L. Gore & Associates, Inc.
    • Company Overview
    • Iliac Stent Market Business Overview
    • New Product Development
    • Merger, Acquisition, and Collaboration
    • Certification and Licensing
  • 14.6 Medtronic
    • Company Overview
    • Iliac Stent Market Business Overview
    • New Product Development
    • Merger, Acquisition, and Collaboration
    • Certification and Licensing
  • 14.7 Cook
    • Company Overview
    • Iliac Stent Market Business Overview
    • New Product Development
    • Merger, Acquisition, and Collaboration
    • Certification and Licensing
  • 14.8 Terumo Corporation
    • Company Overview
    • Iliac Stent Market Business Overview
    • New Product Development
    • Merger, Acquisition, and Collaboration
    • Certification and Licensing
  • 14.9 iVascular
    • Company Overview
    • Iliac Stent Market Business Overview
    • New Product Development
    • Merger, Acquisition, and Collaboration
    • Certification and Licensing
  • 14.10 Getinge AB
    • Company Overview
    • Iliac Stent Market Business Overview
    • New Product Development
    • Merger, Acquisition, and Collaboration
    • Certification and Licensing
  • 14.11 Biotronik SE & Co KG
    • Company Overview
    • Iliac Stent Market Business Overview
    • New Product Development
    • Merger, Acquisition, and Collaboration
    • Certification and Licensing

15. Appendix

  • 15.1 List of Figures
  • 15.2 List of Tables
  • 15.3 Research Methodology
  • 15.4 Disclaimer
  • 15.5 Copyright
  • 15.6 Abbreviations and Technical Units
  • 15.7 About Us
  • 15.8 Contact Us

List of Figures

  • Figure 1.1: Trends and Forecast for the Global Iliac Stent Market
  • Figure 2.1: Usage of Iliac Stent Market
  • Figure 2.2: Classification of the Global Iliac Stent Market
  • Figure 2.3: Supply Chain of the Global Iliac Stent Market
  • Figure 3.1: Trends of the Global GDP Growth Rate
  • Figure 3.2: Trends of the Global Population Growth Rate
  • Figure 3.3: Trends of the Global Inflation Rate
  • Figure 3.4: Trends of the Global Unemployment Rate
  • Figure 3.5: Trends of the Regional GDP Growth Rate
  • Figure 3.6: Trends of the Regional Population Growth Rate
  • Figure 3.7: Trends of the Regional Inflation Rate
  • Figure 3.8: Trends of the Regional Unemployment Rate
  • Figure 3.9: Trends of Regional Per Capita Income
  • Figure 3.10: Forecast for the Global GDP Growth Rate
  • Figure 3.11: Forecast for the Global Population Growth Rate
  • Figure 3.12: Forecast for the Global Inflation Rate
  • Figure 3.13: Forecast for the Global Unemployment Rate
  • Figure 3.14: Forecast for the Regional GDP Growth Rate
  • Figure 3.15: Forecast for the Regional Population Growth Rate
  • Figure 3.16: Forecast for the Regional Inflation Rate
  • Figure 3.17: Forecast for the Regional Unemployment Rate
  • Figure 3.18: Forecast for Regional Per Capita Income
  • Figure 3.19: Driver and Challenges of the Iliac Stent Market
  • Figure 4.1: Global Iliac Stent Market by Type in 2019, 2025, and 2035
  • Figure 4.2: Trends of the Global Iliac Stent Market ($B) by Type
  • Figure 4.3: Forecast for the Global Iliac Stent Market ($B) by Type
  • Figure 4.4: Trends and Forecast for Self-expandable Stents in the Global Iliac Stent Market (2019-2035)
  • Figure 4.5: Trends and Forecast for Balloon-expandable Stents in the Global Iliac Stent Market (2019-2035)
  • Figure 4.6: Trends and Forecast for Others in the Global Iliac Stent Market (2019-2035)
  • Figure 5.1: Global Iliac Stent Market by Artery Lesions in 2019, 2025, and 2035
  • Figure 5.2: Trends of the Global Iliac Stent Market ($B) by Artery Lesions
  • Figure 5.3: Forecast for the Global Iliac Stent Market ($B) by Artery Lesions
  • Figure 5.4: Trends and Forecast for Common Iliac Artery Lesions in the Global Iliac Stent Market (2019-2035)
  • Figure 5.5: Trends and Forecast for Severe Calcified Lesions in the Global Iliac Stent Market (2019-2035)
  • Figure 5.6: Trends and Forecast for Complete Obstructive Lesions in the Global Iliac Stent Market (2019-2035)
  • Figure 6.1: Global Iliac Stent Market by End Use in 2019, 2025, and 2035
  • Figure 6.2: Trends of the Global Iliac Stent Market ($B) by End Use
  • Figure 6.3: Forecast for the Global Iliac Stent Market ($B) by End Use
  • Figure 6.4: Trends and Forecast for Hospitals in the Global Iliac Stent Market (2019-2035)
  • Figure 6.5: Trends and Forecast for Outpatient Facilities in the Global Iliac Stent Market (2019-2035)
  • Figure 6.6: Trends and Forecast for Others in the Global Iliac Stent Market (2019-2035)
  • Figure 7.1: Trends of the Global Iliac Stent Market ($B) by Region (2019-2025)
  • Figure 7.2: Forecast for the Global Iliac Stent Market ($B) by Region (2026-2035)
  • Figure 8.1: Trends and Forecast for the North American Iliac Stent Market (2019-2035)
  • Figure 8.2: North American Iliac Stent Market by Type in 2019, 2025, and 2035
  • Figure 8.3: Trends of the North American Iliac Stent Market ($B) by Type (2019-2025)
  • Figure 8.4: Forecast for the North American Iliac Stent Market ($B) by Type (2026-2035)
  • Figure 8.5: North American Iliac Stent Market by Artery Lesions in 2019, 2025, and 2035
  • Figure 8.6: Trends of the North American Iliac Stent Market ($B) by Artery Lesions (2019-2025)
  • Figure 8.7: Forecast for the North American Iliac Stent Market ($B) by Artery Lesions (2026-2035)
  • Figure 8.8: North American Iliac Stent Market by End Use in 2019, 2025, and 2035
  • Figure 8.9: Trends of the North American Iliac Stent Market ($B) by End Use (2019-2025)
  • Figure 8.10: Forecast for the North American Iliac Stent Market ($B) by End Use (2026-2035)
  • Figure 8.11: Trends and Forecast for the United States Iliac Stent Market ($B) (2019-2035)
  • Figure 8.12: Trends and Forecast for the Mexican Iliac Stent Market ($B) (2019-2035)
  • Figure 8.13: Trends and Forecast for the Canadian Iliac Stent Market ($B) (2019-2035)
  • Figure 9.1: Trends and Forecast for the European Iliac Stent Market (2019-2035)
  • Figure 9.2: European Iliac Stent Market by Type in 2019, 2025, and 2035
  • Figure 9.3: Trends of the European Iliac Stent Market ($B) by Type (2019-2025)
  • Figure 9.4: Forecast for the European Iliac Stent Market ($B) by Type (2026-2035)
  • Figure 9.5: European Iliac Stent Market by Artery Lesions in 2019, 2025, and 2035
  • Figure 9.6: Trends of the European Iliac Stent Market ($B) by Artery Lesions (2019-2025)
  • Figure 9.7: Forecast for the European Iliac Stent Market ($B) by Artery Lesions (2026-2035)
  • Figure 9.8: European Iliac Stent Market by End Use in 2019, 2025, and 2035
  • Figure 9.9: Trends of the European Iliac Stent Market ($B) by End Use (2019-2025)
  • Figure 9.10: Forecast for the European Iliac Stent Market ($B) by End Use (2026-2035)
  • Figure 9.11: Trends and Forecast for the German Iliac Stent Market ($B) (2019-2035)
  • Figure 9.12: Trends and Forecast for the French Iliac Stent Market ($B) (2019-2035)
  • Figure 9.13: Trends and Forecast for the Spanish Iliac Stent Market ($B) (2019-2035)
  • Figure 9.14: Trends and Forecast for the Italian Iliac Stent Market ($B) (2019-2035)
  • Figure 9.15: Trends and Forecast for the United Kingdom Iliac Stent Market ($B) (2019-2035)
  • Figure 10.1: Trends and Forecast for the APAC Iliac Stent Market (2019-2035)
  • Figure 10.2: APAC Iliac Stent Market by Type in 2019, 2025, and 2035
  • Figure 10.3: Trends of the APAC Iliac Stent Market ($B) by Type (2019-2025)
  • Figure 10.4: Forecast for the APAC Iliac Stent Market ($B) by Type (2026-2035)
  • Figure 10.5: APAC Iliac Stent Market by Artery Lesions in 2019, 2025, and 2035
  • Figure 10.6: Trends of the APAC Iliac Stent Market ($B) by Artery Lesions (2019-2025)
  • Figure 10.7: Forecast for the APAC Iliac Stent Market ($B) by Artery Lesions (2026-2035)
  • Figure 10.8: APAC Iliac Stent Market by End Use in 2019, 2025, and 2035
  • Figure 10.9: Trends of the APAC Iliac Stent Market ($B) by End Use (2019-2025)
  • Figure 10.10: Forecast for the APAC Iliac Stent Market ($B) by End Use (2026-2035)
  • Figure 10.11: Trends and Forecast for the Japanese Iliac Stent Market ($B) (2019-2035)
  • Figure 10.12: Trends and Forecast for the Indian Iliac Stent Market ($B) (2019-2035)
  • Figure 10.13: Trends and Forecast for the Chinese Iliac Stent Market ($B) (2019-2035)
  • Figure 10.14: Trends and Forecast for the South Korean Iliac Stent Market ($B) (2019-2035)
  • Figure 10.15: Trends and Forecast for the Indonesian Iliac Stent Market ($B) (2019-2035)
  • Figure 11.1: Trends and Forecast for the ROW Iliac Stent Market (2019-2035)
  • Figure 11.2: ROW Iliac Stent Market by Type in 2019, 2025, and 2035
  • Figure 11.3: Trends of the ROW Iliac Stent Market ($B) by Type (2019-2025)
  • Figure 11.4: Forecast for the ROW Iliac Stent Market ($B) by Type (2026-2035)
  • Figure 11.5: ROW Iliac Stent Market by Artery Lesions in 2019, 2025, and 2035
  • Figure 11.6: Trends of the ROW Iliac Stent Market ($B) by Artery Lesions (2019-2025)
  • Figure 11.7: Forecast for the ROW Iliac Stent Market ($B) by Artery Lesions (2026-2035)
  • Figure 11.8: ROW Iliac Stent Market by End Use in 2019, 2025, and 2035
  • Figure 11.9: Trends of the ROW Iliac Stent Market ($B) by End Use (2019-2025)
  • Figure 11.10: Forecast for the ROW Iliac Stent Market ($B) by End Use (2026-2035)
  • Figure 11.11: Trends and Forecast for the Middle Eastern Iliac Stent Market ($B) (2019-2035)
  • Figure 11.12: Trends and Forecast for the South American Iliac Stent Market ($B) (2019-2035)
  • Figure 11.13: Trends and Forecast for the African Iliac Stent Market ($B) (2019-2035)
  • Figure 12.1: Porter's Five Forces Analysis of the Global Iliac Stent Market
  • Figure 12.2: Market Share (%) of Top Players in the Global Iliac Stent Market (2025)
  • Figure 13.1: Growth Opportunities for the Global Iliac Stent Market by Type
  • Figure 13.2: Growth Opportunities for the Global Iliac Stent Market by Artery Lesions
  • Figure 13.3: Growth Opportunities for the Global Iliac Stent Market by End Use
  • Figure 13.4: Growth Opportunities for the Global Iliac Stent Market by Region
  • Figure 13.5: Emerging Trends in the Global Iliac Stent Market

List of Tables

  • Table 1.1: Growth Rate (%, 2024-2025) and CAGR (%, 2026-2035) of the Iliac Stent Market by Type, Artery Lesions, and End Use
  • Table 1.2: Attractiveness Analysis for the Iliac Stent Market by Region
  • Table 1.3: Global Iliac Stent Market Parameters and Attributes
  • Table 3.1: Trends of the Global Iliac Stent Market (2019-2025)
  • Table 3.2: Forecast for the Global Iliac Stent Market (2026-2035)
  • Table 4.1: Attractiveness Analysis for the Global Iliac Stent Market by Type
  • Table 4.2: Market Size and CAGR of Various Type in the Global Iliac Stent Market (2019-2025)
  • Table 4.3: Market Size and CAGR of Various Type in the Global Iliac Stent Market (2026-2035)
  • Table 4.4: Trends of Self-expandable Stents in the Global Iliac Stent Market (2019-2025)
  • Table 4.5: Forecast for Self-expandable Stents in the Global Iliac Stent Market (2026-2035)
  • Table 4.6: Trends of Balloon-expandable Stents in the Global Iliac Stent Market (2019-2025)
  • Table 4.7: Forecast for Balloon-expandable Stents in the Global Iliac Stent Market (2026-2035)
  • Table 4.8: Trends of Others in the Global Iliac Stent Market (2019-2025)
  • Table 4.9: Forecast for Others in the Global Iliac Stent Market (2026-2035)
  • Table 5.1: Attractiveness Analysis for the Global Iliac Stent Market by Artery Lesions
  • Table 5.2: Market Size and CAGR of Various Artery Lesions in the Global Iliac Stent Market (2019-2025)
  • Table 5.3: Market Size and CAGR of Various Artery Lesions in the Global Iliac Stent Market (2026-2035)
  • Table 5.4: Trends of Common Iliac Artery Lesions in the Global Iliac Stent Market (2019-2025)
  • Table 5.5: Forecast for Common Iliac Artery Lesions in the Global Iliac Stent Market (2026-2035)
  • Table 5.6: Trends of Severe Calcified Lesions in the Global Iliac Stent Market (2019-2025)
  • Table 5.7: Forecast for Severe Calcified Lesions in the Global Iliac Stent Market (2026-2035)
  • Table 5.8: Trends of Complete Obstructive Lesions in the Global Iliac Stent Market (2019-2025)
  • Table 5.9: Forecast for Complete Obstructive Lesions in the Global Iliac Stent Market (2026-2035)
  • Table 6.1: Attractiveness Analysis for the Global Iliac Stent Market by End Use
  • Table 6.2: Market Size and CAGR of Various End Use in the Global Iliac Stent Market (2019-2025)
  • Table 6.3: Market Size and CAGR of Various End Use in the Global Iliac Stent Market (2026-2035)
  • Table 6.4: Trends of Hospitals in the Global Iliac Stent Market (2019-2025)
  • Table 6.5: Forecast for Hospitals in the Global Iliac Stent Market (2026-2035)
  • Table 6.6: Trends of Outpatient Facilities in the Global Iliac Stent Market (2019-2025)
  • Table 6.7: Forecast for Outpatient Facilities in the Global Iliac Stent Market (2026-2035)
  • Table 6.8: Trends of Others in the Global Iliac Stent Market (2019-2025)
  • Table 6.9: Forecast for Others in the Global Iliac Stent Market (2026-2035)
  • Table 7.1: Market Size and CAGR of Various Regions in the Global Iliac Stent Market (2019-2025)
  • Table 7.2: Market Size and CAGR of Various Regions in the Global Iliac Stent Market (2026-2035)
  • Table 8.1: Trends of the North American Iliac Stent Market (2019-2025)
  • Table 8.2: Forecast for the North American Iliac Stent Market (2026-2035)
  • Table 8.3: Market Size and CAGR of Various Type in the North American Iliac Stent Market (2019-2025)
  • Table 8.4: Market Size and CAGR of Various Type in the North American Iliac Stent Market (2026-2035)
  • Table 8.5: Market Size and CAGR of Various Artery Lesions in the North American Iliac Stent Market (2019-2025)
  • Table 8.6: Market Size and CAGR of Various Artery Lesions in the North American Iliac Stent Market (2026-2035)
  • Table 8.7: Market Size and CAGR of Various End Use in the North American Iliac Stent Market (2019-2025)
  • Table 8.8: Market Size and CAGR of Various End Use in the North American Iliac Stent Market (2026-2035)
  • Table 8.9: Trends and Forecast for the United States Iliac Stent Market (2019-2035)
  • Table 8.10: Trends and Forecast for the Mexican Iliac Stent Market (2019-2035)
  • Table 8.11: Trends and Forecast for the Canadian Iliac Stent Market (2019-2035)
  • Table 9.1: Trends of the European Iliac Stent Market (2019-2025)
  • Table 9.2: Forecast for the European Iliac Stent Market (2026-2035)
  • Table 9.3: Market Size and CAGR of Various Type in the European Iliac Stent Market (2019-2025)
  • Table 9.4: Market Size and CAGR of Various Type in the European Iliac Stent Market (2026-2035)
  • Table 9.5: Market Size and CAGR of Various Artery Lesions in the European Iliac Stent Market (2019-2025)
  • Table 9.6: Market Size and CAGR of Various Artery Lesions in the European Iliac Stent Market (2026-2035)
  • Table 9.7: Market Size and CAGR of Various End Use in the European Iliac Stent Market (2019-2025)
  • Table 9.8: Market Size and CAGR of Various End Use in the European Iliac Stent Market (2026-2035)
  • Table 9.9: Trends and Forecast for the German Iliac Stent Market (2019-2035)
  • Table 9.10: Trends and Forecast for the French Iliac Stent Market (2019-2035)
  • Table 9.11: Trends and Forecast for the Spanish Iliac Stent Market (2019-2035)
  • Table 9.12: Trends and Forecast for the Italian Iliac Stent Market (2019-2035)
  • Table 9.13: Trends and Forecast for the United Kingdom Iliac Stent Market (2019-2035)
  • Table 10.1: Trends of the APAC Iliac Stent Market (2019-2025)
  • Table 10.2: Forecast for the APAC Iliac Stent Market (2026-2035)
  • Table 10.3: Market Size and CAGR of Various Type in the APAC Iliac Stent Market (2019-2025)
  • Table 10.4: Market Size and CAGR of Various Type in the APAC Iliac Stent Market (2026-2035)
  • Table 10.5: Market Size and CAGR of Various Artery Lesions in the APAC Iliac Stent Market (2019-2025)
  • Table 10.6: Market Size and CAGR of Various Artery Lesions in the APAC Iliac Stent Market (2026-2035)
  • Table 10.7: Market Size and CAGR of Various End Use in the APAC Iliac Stent Market (2019-2025)
  • Table 10.8: Market Size and CAGR of Various End Use in the APAC Iliac Stent Market (2026-2035)
  • Table 10.9: Trends and Forecast for the Japanese Iliac Stent Market (2019-2035)
  • Table 10.10: Trends and Forecast for the Indian Iliac Stent Market (2019-2035)
  • Table 10.11: Trends and Forecast for the Chinese Iliac Stent Market (2019-2035)
  • Table 10.12: Trends and Forecast for the South Korean Iliac Stent Market (2019-2035)
  • Table 10.13: Trends and Forecast for the Indonesian Iliac Stent Market (2019-2035)
  • Table 11.1: Trends of the ROW Iliac Stent Market (2019-2025)
  • Table 11.2: Forecast for the ROW Iliac Stent Market (2026-2035)
  • Table 11.3: Market Size and CAGR of Various Type in the ROW Iliac Stent Market (2019-2025)
  • Table 11.4: Market Size and CAGR of Various Type in the ROW Iliac Stent Market (2026-2035)
  • Table 11.5: Market Size and CAGR of Various Artery Lesions in the ROW Iliac Stent Market (2019-2025)
  • Table 11.6: Market Size and CAGR of Various Artery Lesions in the ROW Iliac Stent Market (2026-2035)
  • Table 11.7: Market Size and CAGR of Various End Use in the ROW Iliac Stent Market (2019-2025)
  • Table 11.8: Market Size and CAGR of Various End Use in the ROW Iliac Stent Market (2026-2035)
  • Table 11.9: Trends and Forecast for the Middle Eastern Iliac Stent Market (2019-2035)
  • Table 11.10: Trends and Forecast for the South American Iliac Stent Market (2019-2035)
  • Table 11.11: Trends and Forecast for the African Iliac Stent Market (2019-2035)
  • Table 12.1: Product Mapping of Iliac Stent Suppliers Based on Segments
  • Table 12.2: Operational Integration of Iliac Stent Manufacturers
  • Table 12.3: Rankings of Suppliers Based on Iliac Stent Revenue
  • Table 13.1: New Product Launches by Major Iliac Stent Producers (2019-2025)
  • Table 13.2: Certification Acquired by Major Competitor in the Global Iliac Stent Market